Cultivation Technology Considerations Within the Cell-Based Scale-Up Continuum, Upcoming Webinar Hosted by Xtalks

Share Article

In this free webinar, the featured speaker will discuss the variety of available cell-based production platforms, ranging from pilot to mid-range scales. The presentation will outline unique cultivation technology throughout the production scale, including GMP-grade control and sterilization techniques. Attendees will gain insight into how the design of the incubation systems should support both clinical and pharmaceutical applications, starting with research and leading to development, manufacturing and scale-up.

Small and mid-size facilities have an increased need for static, precision-controlled culture incubators with an array of sizes to facilitate small, personalized medicine assays through large-capacity units that house gentle agitation machinery for biological expression.

Culture-based production of cell-derived biologics and whole-cell therapies continues to permeate the biopharmaceutical market. In 2019, seven of the ten best-selling drugs were biologics. Pharmaceutical organizations are rapidly developing new culture-based therapeutics and techniques, from therapeutic antibodies and proteins to recombinant hormones and clotting factors. Regenerative drugs, mesenchymal stromal cell (MSC)-derived materials and engineered tissue production are also emerging fields.

The scale of clinical cell-based therapy is vast, ranging from personalized, benchtop culturing platforms to multi-liter bioprocess techniques. Facilities expanding highly specialized cell lines for use in therapies require scale-ups that avoid the shear-damage and stress that can occur when using bioreactors. For this reason, small and mid-size facilities have an increased need for static, precision-controlled culture incubators with an array of sizes to facilitate small, personalized medicine assays through large-capacity units that house gentle agitation machinery for biological expression.

Register for this webinar to hear an expert from PHCNA discuss the “other side” of cell and biologic production that doesn’t require stirred bioreactors. We will explore different cell expression platforms that enable various cell-based manufacturing within the small- and medium-range scale of production, including GMP-grade control and sterilization techniques.

Join Holly Hattaway, Incubator Product Specialist, PHC Corporation of North America, for the live webinar on Wednesday, May 5, 2021 at 1pm EDT (10am PDT).
For more information, or to register for this event, visit Cultivation Technology Considerations Within the Cell-Based Scale-Up Continuum.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Ayesha Rashid
Xtalks
+1 (416) 977-6555 x 272
Email >
Visit website